AnaptysBio Inc buy JPMorgan Chase & Co.
Start price
05.03.25
/
50%
€15.00
Target price
05.03.26
€38.99
Performance (%)
153.33%
Price
12.12.25
€38.00
Summary
This prediction is currently active. With a performance of 153.33% the BUY prediction by JPMorgan_Chase___Co_ is a big success. This prediction currently runs until 05.03.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 0.529% | 0.529% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target raised by analysts at JPMorgan Chase & Co. from $36.00 to $42.00. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat